The Cardiac Safety Research Consortium
is dedicated to advancing scientific knowledge on cardiac safety for new and existing medical products by building a collaborative environment based upon the principles of the FDA’s Critical Path Initiative as well as other public health priorities.
Never miss a beat.
LinkedIn: Cardiac Safety Research Consortium
CSRC forms collaborative partnership with AACP
The Cardiac Safety Research Consortium (CSRC) is very pleased to announce the signing of a collaborative Memorandum of Understanding with the American College of Clinical Pharmacology (ACCP).
Through the partnership, CSRC and AACP will:
- Develop, plan, and conduct various educational events and programs
- Develop and produce research and policy statements/position papers relevant to the fields of clinical pharmacology and the cardiac and vascular safety of medical products.
We're planning for the following meetings:
September 7: Defining the Clinical and Regulatory Landscape for Cardiogenic Shock
September 26-27: DCRI/Stanford Center for Clinical Research CEC Summit -- CSRC committee chair to moderate
January 23: Driving Efficiencies in Clinical Trials through the use of Cardiac Biomarkers
Details coming soon.
News & Updates
CSRC and ACCP Sign Collaborative Memorandum of Understading
Through the partnership, CSRC and ACCP will develop, plan, and conduct various educational events and programs and produce research and policy statements/position papers regarding clinical pharmacology and cardiac and vascular safety of medical products.
Follow us on LinkedIn
Follow the CSRC on LinkedIn to stay current on cardiac safety topics.
CiPA Update, Slides, and Synopsis on Site
Read the June CiPA update from Jennifer Pierson, HESI senior scientific program manager and download the presentation slides and meeting synopsis from our New Advances in the Assessment of Drug-Induced Arrhythmias and the Comprehensive In Vitro Proarrhythmia Assay (CiPA) meeting.
Initiatives and Projects
For more than a decade, we have made great strides in advancing knowledge of cardiac safety in clinical research through conferences, publications, and research projects. We are currently planning for the following think tanks in 2018:
New Advances in the Assessment of Drug-Induced Arrhythmias and the Comprehensive In Vitro Proarrythmia Assay (CiPA) (Spring)
Understanding Cardiogenic Shock and Defining the Concept of “Pre-shock” (Fall)
- Concept of "pre-shock" and develop consensus statements for clinical/research use
- Mechanical circulatory support in treating "pre-shock"
Novel Approaches for the Evaluation of Mobile Technologies in CV Medicine — Scientific rigor, Innovative Methods, Regulatory Acceptance (Fall)
- Integrating devices into supporting cardiovascular safety and efficacy endpoints
- Promised efficiencies of mobile technology in clinical trials
- Device features, patient features, endpoint validation, and regulatory considerations
- Arrhythmia Normal Limits Combined Holter/12 Lead ECG Analysis
- CSRC Prevention of Sudden Cardiac Death in the Young: National Cardiac Screening Warehouse Pilot Study
Submit Your Ideas
SUBMIT YOUR IDEAS FOR THINK TANKS AND PUBLICATIONS
In order to promote the spirit of collaboration the CSRC highly values, we ask that you submit your ideas for future research projects, think tanks, and white papers. By hearing directly from our members, we can ensure that the topics researched, discussed and published are important to you.
CSRC members benefit from engaging in pre-competitive collaboration with cardiac safety professionals on vital research topics and projects. Working together, we have the opportunity to accomplish public health objectives that no single stakeholder could achieve on its own. The CSRC takes to heart the African proverb shared at one of our pediatric safety think tanks:
“If you want to go fast, go alone. If you want to go far, go together.”
In that spirit, we celebrate our second decade of excellence in
cardiac safety research, and going there together.